Navigation Links
Exelixis Announces June 2 Webcast of Its ASCO Investor and Analyst Briefing
Date:5/21/2008

Seven Abstracts Accepted for Presentation at ASCO

SOUTH SAN FRANCISCO, Calif., May 21 /PRNewswire-FirstCall/ -- Exelixis, Inc. (Nasdaq: EXEL) announced today that it will hold an investor and analyst briefing in conjunction with the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) from 6:00 p.m. to 8:00 p.m. CT on Monday, June 2, 2008.

Participants:

-- George A. Scangos, PhD, President and Chief Executive Officer

-- Michael M. Morrissey, PhD, President of Research and Development

-- Gisela M. Schwab, MD, Executive Vice President and Chief Medical

Officer

Topics:

-- XL184 (targets: MET, VEGFR2, RET)

-- XL147 (targets: PI3K)

-- XL765 (targets: PI3K, mTOR)

-- XL647 (targets: EGFR, HER2, VEGFR2)

-- XL880* (targets: MET, VEGFR2)

-- XL281 (targets: RAF)

* XL880 was selected by GlaxoSmithKline in December 2007 for further

development and commercialization.

The event will be webcast and may be accessed in the Event Calendar page under Investors at http://www.exelixis.com.

An archived replay of this webcast will be available until 9:00 p.m. PT/12:00 a.m. ET on July 2, 2008. Access numbers for this replay are: 1-888- 286-8010 (domestic) and +1-617-801-6888 (international); the replay passcode is: 42662164.

ASCO Presentations

Saturday, May 31

-- XL647 (EGFR, HER2, VEGFR2) -- Poster & Discussion

"A phase 1 study of XL647, an EGFR, HER2, VEGFR2 inhibitor,

administered orally daily to patients (pts) with advanced solid

malignancies (ASM)"

Day: Saturday, May 31


'/>"/>

SOURCE Exelixis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
2. Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer
3. Exelixis Announces Closing of Public Offering of Common Stock
4. Exelixis Submits XL880 Diligence Report to GlaxoSmithKline
5. Exelixis Announces November 5 Webcast of its 2007 Third Quarter Financial Results Conference Call
6. Exelixis Announces Third Quarter 2007 Financial Results and Business Update
7. Exelixis Sells 80% Stake in Artemis to Taconic
8. Exelixis Announces December 5 Webcast of Its Third Annual R&D Day
9. Exelixis Announces November 27 Webcast of Presentation at the 19th Annual Piper Jaffray Health Care Conference
10. Exelixis Announces November 28 Webcast of Presentation at the Lazard Capital Markets Fourth Annual Healthcare Conference
11. Reminder: Exelixis Announces December 5 Webcast of Its Third Annual R&D Day

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...Newswire/-Cytochromatodayannouncedtheappointmentof...placeMr.UlrikSporkastheNovoA/SrepresentativeontheC...gedatsixmembers. ,, "WeareverypleasedtowelcomeP...isexperienceandguidanceasCytochromacontinuestomake...maceuticalcompany,"statedAlanLewis,PhD,ChairmanofC...
(Date:11/24/2009)...swire-FirstCall/--IES(Nasdaq: IESC ),aleadingnatio...servicesforthecommercial,industrialandresidentialm...phasbeenawardedacontractfromManhattanTorconJVtoins...BSL-4)replacementfacilityattheU.S.ArmyMedicalResea...trickinFrederick,Md. ,, ThenewUSAMRIIDreplaceme...
(Date:11/24/2009)...vember24/PRNewswire-FirstCall/--deCODE,genetics,In...ticefrom,theNasdaqStockMarketthattradinginthecompa...andaForm25-NSEwillbefiledwiththe,SecuritiesandExch...fromlistingonNasdaq,unlessthecompanyfilesanappealt...sfiledsuchanappeal,which,willstaythesuspensionandd...
(Date:11/24/2009)...24/PRNewswire-FirstCall/--NeurogesX,Inc.(Nasdaq: N...andcommercializingnovelpainmanagementtherapies,ann...cutiveOfficer,isscheduledtopresentatthe21stAnnualP...2,2009atTheNewYorkPalaceHotelinNewYork,NewYork. ,...ficer,willbeavailabletorespondtoquestionsduringthe...
Breaking Biology Technology:Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3
... least 45 girls in grades six through nine are exp...e held June 26 to 28 at Madison Area Technical Co...gy employers to encourage young women to consider ...ture hands-on technical activities that introduce ...ing, electronics and electron microscopy, and info...
...e Douglas Stewart Co. has entered into a distrib...on resellers the products of Honestech, Inc. , an...net Protocol (IP) communication and entertainment ...disclosed. , ,Douglas Stewart sells computer produ...a market of 4,500 academic resellers in the United...
...is is part II of a two-part column on the Food and...cused on the recent controversy over Avandia, Glax...efficacy over safety seems to be so deeply integra...e that this has not always been the case. For much...,s primary mandate was to protect the public,s sa...
Other Biology Technology:Reforming FDA: Focus on safety, let market judge efficacy 2Reforming FDA: Focus on safety, let market judge efficacy 3Reforming FDA: Focus on safety, let market judge efficacy 4Reforming FDA: Focus on safety, let market judge efficacy 5Reforming FDA: Focus on safety, let market judge efficacy 6
(Date:11/23/2009)...ON, WI, November 16, 2009 -- A USDOE and USDA stud..., idle cropland, and cropland pasture could be con...nnial grasses, such as switchgrass, from which bio...tock. Economically viable production of a perennia...ies of biomass are removed annually is expected to...
(Date:11/23/2009)...HAM, N.H. University of New Hampshire microbiolog...98,115 to advance understanding of the actinorhiza...o enrich nutrient-poor and contaminated soils. ,...A) awarded Tisa, a professor of molecular, cellula... symbiotic relationship between the bacteria Frank...
(Date:11/23/2009)...versity of Southern California biomedical engineer...lop a new tool to help clinicians distinguish card...hronic problems manageable with drugs and lifestyl... inserted into the arteries feeding the heart, off...) of these blood vessels, often revealing deposits...
Breaking Biology News(10 mins):Switchgrass produces biomass efficiently 2UNH prof. receives nearly $500,000 to research environmentally significant plants 2Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2Odd Behaviors on Ambien Linked to Brain Circuitry 50681 1Odd Behaviors on Ambien Linked to Brain Circuitry 50681 2 28RED 29ZONES Launch at First U2 360 Degrees Concert in Barcelona 50678 1 28RED 29ZONES Launch at First U2 360 Degrees Concert in Barcelona 50678 2 28RED 29ZONES Launch at First U2 360 Degrees Concert in Barcelona 50678 3Prostate cancer patients disease free after 5 years likely to be disease free after 10 years 50676 1
...ate University makes an animal heart pump much lik...animal,s body, allowing researchers to expedite th...t surgery. The machine saves researchers time and ...chnologies in a realistic surgical environment, wi...clinical trials. , , Currently, most medical devi...
...predators detect common forms of prey more easily....MC Ecology found that birds will target salamande...ir behavior in response to alterations in the rati...ick, from the University of Tennessee, worked with...of the prevalence of a dorsal stripe among a group...
...l Oceanic and Atmospheric Administration (NOAA) ha...new cooperative institute which will be headquarte...) at Florida Atlantic University in Fort Pierce, F...Carolina Wilmington (UNCW). This is the single lar...U since their inception. The Cooperative Institute...
Other Biology News:'Beating' heart machine expedites research and development of new surgical tools, techniques 2NOAA awards $22.5 million to Harbor Branch/FAU and UNCW for new cooperative institute 2NOAA awards $22.5 million to Harbor Branch/FAU and UNCW for new cooperative institute 3
Rabbit Anti-MSY2 / YBOX2 Polyclonal Antibody, Unconjugated from Abcam
Anti-SAPK / JNK Antibody, Unconjugated from Cell Signaling Technology
L-Selenomethionine from Calbiochem
PAP PEN from Invitrogen
Biology Products: